Crinetics CRNX 深 沪
已收盘 08-07 16:00:00 美东时间
84.08
+0.160
+0.19%
华盛通- 最 高84.298
- 今 开83.95
- 成交量 188.87万股
- 最 低 83.75
- 昨 收 83.92
- 总市值 449.88万
- 52周最高 84.298
- 市盈率 静 --
- 换手率 3529.94%
- 52周最低 28.73
- 委 比 26.74%
- 总股本 5.35万
- 历史最高 84.298
- 量 比 0.93
- 振 幅 0.65%
- 历史最低 1.10
- 每 手 1
- 风险率 13.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nvidia, Vertex Pharmaceuticals And More On CNBC’s ‘Final Trades’
The Halftime Report Final Trades featured stock picks from Bryn Talkington, Jim Lebenthal, Liz Young Thomas, and Joseph M. Terranova.
07-09 19:45
创新药物实现从模仿、跟进开发到首创的跨越！恒瑞医药双箭待发，中国生物制药揽大额BD！科创创新药ETF汇添富(589120)一度涨超4%
7月9日，A股三大指数涨跌不一，创新药板块开盘直线走高。科创创新药ETF汇添富(589120)一度涨超4%，截至10:05，涨2.05%。资金面上...
07-09 11:19
Crude Oil Moves Higher; Rivian Automotive Shares Plunge
US stocks decline on Tuesday, with Nasdaq falling 0.61% and S&P 500 dropping 0.24%. Consumer staples shares rise 1.8% while tech stocks fall 2.1%. Logistics Manager's Index records strongest growth since March 2022.
07-08 01:06
Vertex Sees Over $5 Billion Peak Sales Potential From Crinetics Assets
Vertex to acquire Crinetics for $10 billion, adding approved acromegaly drug Palsonify and late-stage CAH candidate atumelnant to its rare disease portfolio.
07-07 20:24
Cantor Fitzgerald Downgrades Crinetics Pharmaceuticals to Neutral
Cantor Fitzgerald analyst Josh Schimmer downgrades Crinetics Pharmaceuticals (NASDAQ:CRNX) from Overweight to Neutral.
07-07 19:59
Crinetics Pharmaceuticals Stock Doubles After The Close: Here's Why
Crinetics Pharmaceuticals shares are trading higher in Monday's after-hours session after the company announced it will be acquired by Vertex.
07-07 04:30
Vertex Pharmaceuticals Agrees To Acquire Crinetics Pharmaceuticals For $85/Share In Cash
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for
07-07 04:05
Crinetics Pharmaceuticals Submits Marketing Authorization Application in Brazil for Palsonify In Acromegaly
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) today announced the submission of a Marketing Authorization Application (MAA) to Brazil's National Health Surveillance Agency (ANVISA) for PALSONIFY™ (paltusotine),
03-27 04:15
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Preview: Crinetics Pharmaceuticals's Earnings
Crinetics Pharmaceuticals (NASDAQ:CRNX) is preparing to release its quarterly e...
02-26 00:02
